Article
08 Mar 2021
Substantiating Environmental Claims In The Cleantech Industry
AUTHORS CONTENT
Article
08 Jun 2020
Protecting COVID IP From Cyber-Spies
Article
23 Dec 2019
Potential Increase To Canadian Biologic Drug Data Protection Scratched From USMCA Free Trade Deal
Article
24 Sep 2019
Another Round In The US CRISPR Patent Dispute
Article
15 May 2019
Patenting Diagnostic Methods In Canada: A Glimmer Of Light From Our Southern Neighbours?
Article
01 Oct 2018
Broad Institute Prevails In Recent Round Of The US CRISPR Patent Battle
Article
30 Aug 2018
The Battle To Control CRISPR IP Continues
Article
27 Mar 2018
Procedures And Strategies For Pharmaceutical Brands
Article
22 Mar 2018
Commercialisation Des « Aliments Malsains » Auprès Des Enfants : Le Législateur Adopte Une Initiative Mise En Place Volontairement Par L'Industrie En 2007
Article
22 Mar 2018
Publicité d'Appareils Médicaux : les Normes de Publicité sont Maintenant Ouvertes pour les Affaires
Article
07 Mar 2018
Medical Device Ads - Ad Standards Is Now Open For Business
Article
07 Mar 2018
Marketing "Unhealthy Food" To Children: Legislators Move On An Initiative That Industry Voluntarily Put In Place In 2007
Article
03 Mar 2017
Life Sciences - 2016 Year In Review
Article
03 Mar 2017
Revue de l'année 2016 – Sciences de la vie
Article
09 Sep 2016
Evolution Of The Common General Knowledge: Humanized Antibody Claims Upheld At The Canadian Patent Appeal Board
Article
14 Jul 2016
Method Of Cryopreservation Is Patentable Subject Matter: US Federal Circuit
Article
07 Jul 2016
US Supreme Court Declines To Review Ariosa V. Sequenom: A Missed Opportunity To Clarify The Eligibility Of Diagnostic Patents
Article
14 Apr 2016
Regulators Throw Open The Doors To Complex Biosimilars To Reduce Drug Costs
Article
14 Mar 2014
More Clarity For Complex Biosimilars: Europe Approved The First Follow-On Monoclonal Antibodies – Canada Follows Suit
Article
05 Mar 2013
THALOMID Is Not An Innovative Drug Eligible For Canadian Data Protection